LymphoSign - Crunchbase Company Profile & Funding

Q: Where is LymphoSign's headquarters?

LymphoSign is located in Markham, Ontario, Canada.

Q: Who invested in LymphoSign?

LymphoSign has 2 investors including GeneChem And VenGrowth Asset Management.

Q: When was the last funding round for LymphoSign?

LymphoSign closed its last funding round on obfuscated from a Series A round.

Q: How much funding has LymphoSign raised to date?

LymphoSign has raised obfuscated.

Overview

LymphoSign

Total Funding

obfuscation

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About LymphoSign

CB Rank

3268294

LymphoSign Inc., is a Toronto-based drug developer.

Acquired by

Aegera Therapeutics

Founded

obfuscation

Private

Series A

Markham, Ontario, Canada

11-50

lymphosign.com/

Biotechnology

Health Care

Medical

Medical Device

Funding Rounds

Series A

OBF

obfuscation

Details

Operating Status

Closed

Company Type

For Profit

About the Company

LymphoSign is a pharmaceutical company that is focused on the development of drugs for blood cancers. LymphoSign was acquired by Aegera Therapeutics in August 2007. LymphoSign was founded in 2000 and is based in Markham, Canada.

Phone Number

(905) 530-2333

Predictions & Insights

Products & Services

LymphoSign Journal

A scientific publication focusing on clinical, translational, and basic research in immunology and related fields, providing a platform for discussing clinical observations, therapies, and disease mechanisms.

LymphoSign Journal

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - LymphoSign	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - LymphoSign	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - LymphoSign	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - LymphoSign	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - LymphoSign	2	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - LymphoSign	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - LymphoSign	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - LymphoSign	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - LymphoSign	2	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - LymphoSign	2	obfuscated obfuscation	—	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
GeneChem	—	Series A - LymphoSign	—
GeneChem	—	Series A - LymphoSign	—
GeneChem	—	Series A - LymphoSign	—
GeneChem	—	Series A - LymphoSign	—
GeneChem	—	Series A - LymphoSign	—